Impact of the Metabolic Syndrome on the Incidence of Neuropathy in Obese Subjects

NCT02689661 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 177

Last updated 2020-02-05

No results posted yet for this study

Summary

The primary purpose of this study is to discover modifiable risk factors for the development of neuropathy, specifically looking at the metabolic syndrome.

Conditions

Sponsors & Collaborators

  • Brian Callaghan

    lead OTHER

Principal Investigators

  • Brian C Callaghan, MD, MS · University of Michigan

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2019-07-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02689661 on ClinicalTrials.gov